Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses

WT Xie, YQ Wang, ZS Xiang, ZS Du, SX Huang… - Journal of Ovarian …, 2022 - Springer
Objective Ovarian cancer is the most deadly deadliest gynecological tumor in the female
reproductive system. Therefore, the present study sought to determine the diagnostic …

The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian …

S Muhammad, RJ Azwan, RS Rita, R Susanti… - Plos one, 2023 - journals.plos.org
Introduction A study of tumor resectability in pre-operative patients with advanced epithelial
ovarian cancer is required to predict primary surgical benefits accurately. This study aims to …

Microfluidic devices as miniaturized screening and diagnostic approaches for gynecological cancers detection

S Suboh, A Ogata - Canadian Journal of Chemistry, 2024 - cdnsciencepub.com
Gynecological cancers, including cervical, endometrial, and ovarian cancer, contribute to a
significant portion of female cancer-related deaths. Despite advancements in cancer …

A signature of circulating miRNAs predicts the prognosis and therapeutic outcome of taxane/platinum regimen in advanced ovarian carcinoma patients

R Pal, T Choudhury, M Ghosh, M Vernakar… - Clinical and …, 2024 - Springer
Purpose Ovarian carcinoma (OC) is ranked as the eighth most lethal gynecological cancer
due to late diagnosis and high recurrence. Existing biomarkers are lacking to predict the …

Diagnostic value of serum CA125 combined with PET/CT in ovarian cancer and tuberculous peritonitis in female patients

P Wang, Y Feng, H Qi, H Feng, Y Chen, G Zeng… - Abdominal …, 2023 - Springer
Purpose To evaluate the diagnostic value of serum CA125 combined with 18F-FDG PET/CT
in ovarian cancer (OC) and tuberculous peritonitis (TBP) in female patients and to establish …

Discovery of T Cell Epitopes for Cancer Immunotherapy

G Zuleger, AM Krackhardt, M Hiltensperger - 2024 - Springer
T cell antigens are important targets for cancer immunotherapy in the form of cancer
vaccines or adoptive T cell therapy. These antigens are a result of tumorigenesis and can be …